Feline atopic dermatitis is the inflammation of the skin seen in the cats. Feline atopic dermatitis is often triggered by causative allergens which are either inhaled or through skin contact leading to inflammation of the skin.
This report contains market size and forecasts of Feline Atopic Dermatitis Drug in Global, including the following market information:
Global Feline Atopic Dermatitis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Feline Atopic Dermatitis Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Feline Atopic Dermatitis Drug include Bausch Health Companies, Bayer, Pfizer, Novartis, Sanofi, Eli Lily, Bristol-Myers Squibb and C. H. Boehringer Sohn, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Feline Atopic Dermatitis Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Feline Atopic Dermatitis Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Feline Atopic Dermatitis Drug Market Segment Percentages, by Type, 2021 (%)
Corticosteroids
Antihistamines
Antibiotics
Global Feline Atopic Dermatitis Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Feline Atopic Dermatitis Drug Market Segment Percentages, by Application, 2021 (%)
Veterinary Pharmacy
Retail Pharmacy
Online Pharmacy
Global Feline Atopic Dermatitis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Feline Atopic Dermatitis Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Feline Atopic Dermatitis Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Feline Atopic Dermatitis Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch Health Companies
Bayer
Pfizer
Novartis
Sanofi
Eli Lily
Bristol-Myers Squibb
C. H. Boehringer Sohn